Clinical Trial

Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer

Study acronym: RTL-DART
Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized, single centre, single blinded prospective study comparing the standard of care imaging guided radiation therapy and daily adaptive radiotherapy (ART) for submandibular gland-sparing in head and neck cancer
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-09; most recent amendment 2026-03-03.
Trial Details
NCT Number NCT07348887
Lead Sponsor University Health Network, Toronto
Conditions Squamous Cell Cancer of Head and Neck (SCCHN)
Enrollment 50 participants
Start Date 2025-10-15
Primary Completion 2029-10-01 (estimated)
Study Completion 2029-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-04